Thus, tissue editing techniques disclose that the wide-ranging functions of PPARα/γ agonists in tumor tissues may be selectively focused on differential reprogramming patterns of cancer hallmarks, induction of tumor cell death, and on facilitating edited non-oncogene addiction. The gene discussed is PPARA; the disease is cancer.